Search all trials

Find therapies in clinical trials near you – page 3

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Schizophrenia

Not yet recruiting

Investigational

Study on Cannabidiol as an Add-On Treatment for Patients with Early Schizophrenia

Investigational

Germany

Participants:18–64 years · 65+ years
Substances:Cannabidiol

Contact Research Centre

Schizophrenia+2

Not yet recruiting

Registered drugNo placebo

Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure

Registered drugNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Clozapine

Contact Research Centre

Schizophrenia

Not recruiting

InvestigationalNo placebo

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

InvestigationalNo placebo

Austria

Participants:18–64 years
Substances:Iclepertin

Contact Research Centre

Schizophrenia

Not recruiting

Registered drugNo placebo

Relative Bioavailability of LY03010 versus Paliperidone Palmitate (with Risperidone background) in Healthy Volunteers for Schizophrenia

Registered drugNo placebo

Portugal

Participants:18–64 years · Healthy volunteers
Substances:Risperidone

Contact Research Centre

Schizophrenia

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Cariprazine for Adolescents (13-17 years) with Schizophrenia

Registered drug

Bulgaria

Participants:0–17 years
Substances:Cariprazine

Contact Research Centre

Schizophrenia

Not recruiting

InvestigationalNo placebo

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms

InvestigationalNo placebo

Bulgaria

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Schizophrenia

Not recruiting

Registered drugNo placebo

Study on Rituximab for Adults with Schizophrenia Spectrum Disorder

Registered drugNo placebo

Sweden

Participants:18–64 years
Substances:Rituximab

Contact Research Centre

Schizophrenia

Not recruiting

Investigational

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Valbenazine Ditosylate

Contact Research Centre

Schizophrenia

Not recruiting

Registered drugNo placebo

Study on Tolcapone for Improving Cognitive Symptoms in Patients with Long-Standing Schizophrenia

Registered drugNo placebo

Spain

Participants:18–64 years
Substances:Tolcapone

Contact Research Centre

Schizophrenia+1

Not recruiting

Investigational

Study on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients

Investigational

Bulgaria

Participants:18–64 years
Substances:(2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid

Contact Research Centre

Schizophrenia

Not recruiting

Investigational

Study of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms

Investigational

Bulgaria

Participants:18–64 years · 65+ years
Substances:Trospium Chloride

Contact Research Centre

Schizophrenia

Not recruiting

Registered drugNo placebo

Study on the Safety and Tolerability of Cariprazine for Treating Schizophrenia in Adolescents Aged 13-17

Registered drugNo placebo

Bulgaria

Participants:0–17 years
Substances:Cariprazine

Contact Research Centre

Find therapies in clinical trials near you – page 3

39 trials match your criteria

Schizophrenia

Study on Cannabidiol as an Add-On Treatment for Patients with Early Schizophrenia

Schizophrenia+2

Study on Enhanced Treatment for Schizophrenia, Depression, and Bipolar Disorder Using Esketamine, Bupropion, and Quetiapine for Patients with Initial Treatment Failure

Schizophrenia

Study on Long-Term Safety of Iclepertin for Patients with Schizophrenia Who Completed Previous Trials

Schizophrenia

Relative Bioavailability of LY03010 versus Paliperidone Palmitate (with Risperidone background) in Healthy Volunteers for Schizophrenia

Schizophrenia

Study on the Effectiveness and Safety of Cariprazine for Adolescents (13-17 years) with Schizophrenia

Schizophrenia

Long-term safety study of trospium chloride and xanomeline tartrate combination (KarXT) in patients with inadequately controlled schizophrenia symptoms

Schizophrenia

Study on Rituximab for Adults with Schizophrenia Spectrum Disorder

Schizophrenia

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Schizophrenia

Study on Tolcapone for Improving Cognitive Symptoms in Patients with Long-Standing Schizophrenia

Schizophrenia+1

Study on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients

Schizophrenia

Study of KarXT (trospium chloride and xanomeline tartrate) in patients with inadequately controlled schizophrenia symptoms

Schizophrenia

Study on the Safety and Tolerability of Cariprazine for Treating Schizophrenia in Adolescents Aged 13-17

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.